Back Login for AI Analysis

    ETON (STOCKS)

    Eton Pharmaceutcials, Inc. Common Stock

    $26.050000
    -0.310000 (-1.18%)
    Prev close: $26.360000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Sean E. Brynjelsen
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $710.49M
    Employees
    31
    P/E (TTM)
    -147.43
    P/B (TTM)
    27.26
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Dec 2025)
    Revenues $79.95M
    Benefits Costs and Expenses $84.51M
    Cost Of Revenue $37.21M
    Costs And Expenses $84.51M
    Gross Profit $42.74M
    Nonoperating Income/Loss -$3.71M
    Operating Expenses $43.58M
    Depreciation and Amortization $4.04M
    Research and Development $7.77M
    Other Operating Expenses $31.78M
    Operating Income/Loss -$844.00K
    Income/Loss From Continuing Operations After Tax -$4.60M
    Income/Loss From Continuing Operations Before Tax -$4.56M
    Income Tax Expense/Benefit $43.00K
    Net Income/Loss -$4.60M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$4.60M
    Net Income/Loss Available To Common Stockholders, Basic -$4.60M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$0.17
    Basic Average Shares 26,908,000
    Assets $92.11M
    Current Assets $60.58M
    Inventory $15.42M
    Other Current Assets $45.16M
    Noncurrent Assets $31.53M
    Fixed Assets $326.00K
    Intangible Assets $30.88M
    Other Non-current Assets $329.00K
    Liabilities $65.96M
    Current Liabilities $38.49M
    Accounts Payable $10.98M
    Other Current Liabilities $27.51M
    Noncurrent Liabilities $27.47M
    Equity $26.15M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $26.15M
    Liabilities And Equity $92.11M
    Net Cash Flow From Operating Activities $10.52M
    Net Cash Flow From Operating Activities, Continuing $10.52M
    Net Cash Flow From Investing Activities -$333.00K
    Net Cash Flow From Investing Activities, Continuing -$333.00K
    Net Cash Flow From Financing Activities $815.00K
    Net Cash Flow From Financing Activities, Continuing $815.00K
    Net Cash Flow $11.01M
    Net Cash Flow, Continuing $11.01M
    Comprehensive Income/Loss -$4.60M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$4.60M
    Other Comprehensive Income/Loss $0.00